Savanna Biotherapeutics
Aliso Viejo, US · Founded 2020 · Delaware corporation
Founders & leadership
RS
Robert SpitaleNamed on SEC filing
Board
JW
Jeffrey W. BirdBoard director
KL
Keith LoebnerBoard director
KK
Kim KamdarBoard director
ML
Michael L. SpeiserBoard director
Reported raises · per SEC filings
Form D private placements$37.3M disclosed across 2 rounds · 2022–2025
▶$13MraisedJun 2025 · 30 investors · BiotechnologyRule 506(b)
▶$13MraisedJun 2025 · 30 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey W. BirdDirector
- Robert SpitaleExecutive Officer, Director
- Keith LoebnerDirector
- Kim KamdarDirector
- Offering amount
- $60M
- Amount sold
- $13M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$24.3MraisedNov 2022 · 54 investors · BiotechnologyRule 506(b)
▶$24.3MraisedNov 2022 · 54 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert SpitaleExecutive Officer, Director
- Michael L. SpeiserDirector
- Jeffrey W. BirdDirector
- Offering amount
- $54.3M
- Amount sold
- $24.3M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Savanna Biotherapeutics raised?
- Savanna Biotherapeutics has disclosed $37.3M raised across 2 rounds.
- Where is Savanna Biotherapeutics headquartered?
- Savanna Biotherapeutics is headquartered in Aliso Viejo, US.